Immune Checkpoint Inhibitor Use in Advanced Hepatocellular Carcinoma: A Real-World Analysis of Efficacy and Toxicity.

Cancers (Basel) · 2025 · PMC12468603 · PMID 41008877

Europe PMC DOI

hedged sentences

0.0620

closest p · 1.2× alpha

0.0620

boldest claim

The sentences

showed a trendp = 0.062so close (0.05 < p ≤ 0.1)

did not reach statistical significanceno p-value reported

Receiving ICI beyond the first line showed a trend toward worse PFS (adjusted HR: 1.85; p = 0.062) but did not reach statistical significance.

also in 37,073 other papers

a trend towards significanceno p-value reported

>3 cm) had a trend towards significance.

also in 1,888 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.